Ultrasonographic assessment of postoperative residual curarisation in pediatric patients reversed with neostigmine versus sugammadex: a prospective randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0007420

Enrollment

102

Registered

2022-06-20

Start date

2022-06-20

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : At the end of the surgery, neuromuscular blockade is reversed with 50 mcg/kg of neostigmine or 2mg/kg of sugammadex.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pediatric patients scheduled for surgery under general anesthesia Pediatric patients 2 ~ 12 years of age

Exclusion criteria

Exclusion criteria: Premature infants, a history of previous chest surgery, patients with confirmed upper or lower respiratory tract infections, airway malformations, severe lung disease Body mass index >= 30 Preoperative chest X-ray abnormal findings (eg atelectasis, pneumonia, pneumothorax, pleural effusion, etc.)

Design outcomes

Primary

Measure	Time frame
postoperative residual diaphragmatic paralysis	—

Secondary

Measure	Time frame
Postoperative atelectasis;parasternal muscle thickness;postoperative pulmonary complications;postoperative nausea and vomiting;postoperative pain;postoperative agitation and emergence delirium;adverse event assumed to be cause by study drugs;Time to TOF ratio 0.9 from the administration of study drugs;Time to extubation	—

Countries

Korea, Republic of

Contacts

Public Contactjeayoun kim

Samsung Medical Center

kimjy0705@naver.com+82-2-3410-6580

Outcome results